Literature DB >> 26069147

A Case of Bilateral Trigger Thumbs Secondary to Aromatase Inhibitor.

Jang Hyun Lee1, Jin Young Kim2, Chul Han Kim3.   

Abstract

Entities:  

Year:  2015        PMID: 26069147      PMCID: PMC4479852          DOI: 10.3349/ymj.2015.56.4.1167

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


× No keyword cloud information.
  5 in total

1.  Severe disabling tendinopathy caused by anastrazole.

Authors:  H A Martens; C P Schröder; P J M van der Eerden; P H B Willemse; M D Posthumus
Journal:  Rheumatology (Oxford)       Date:  2007-08-27       Impact factor: 7.580

Review 2.  Aromatase inhibitors and their side effects: what hand surgeons should know.

Authors:  Bryan J Loeffler; R Glenn Gaston
Journal:  J Hand Surg Am       Date:  2010-02-24       Impact factor: 2.230

3.  Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging.

Authors:  Leilani Morales; Steven Pans; Robert Paridaens; Rene Westhovens; Dirk Timmerman; Johan Verhaeghe; Hans Wildiers; Karin Leunen; Frederic Amant; Patrick Berteloot; Ann Smeets; Erik Van Limbergen; Caroline Weltens; Walter Van den Bogaert; Luc De Smet; Ignace Vergote; Marie-Rose Christiaens; Patrick Neven
Journal:  Breast Cancer Res Treat       Date:  2006-10-24       Impact factor: 4.872

4.  Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial.

Authors:  A Buzdar; A Howell; J Cuzick; C Wale; W Distler; G Hoctin-Boes; J Houghton; G Y Locker; J M Nabholtz
Journal:  Lancet Oncol       Date:  2006-08       Impact factor: 41.316

5.  Neoadjuvant treatment of endometrial cancer using anastrozole: a randomised pilot study.

Authors:  Amudha Thangavelu; Matthew J Hewitt; Naomi D Quinton; Sean R Duffy
Journal:  Gynecol Oncol       Date:  2013-09-27       Impact factor: 5.482

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.